Bharat Jagannathan
Bharat Jagannathan is process development senior scientist at Amgen.
Articles
Saroj Ramdas;Renata Varga;Martin Gastens;Twinkle R. Christian;Bharat Jagannathan;Barbara Rellahan;Jillian Brady
March 16th 2021Many biologic drug manufacturers encounter similiar challenges; precompetitive collaboration can help resolve these issues. Representatives of the IQ Consortium’s Biologics CMC Leadership Group describe efforts to address the safe handling of biologic drugs in closed-system transfer devices in healthcare settings and the need for phase-appropriate specifications.
Latest Updated Articles
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: November 15th 2024 | Updated: November 20th 2024
Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs
Published: October 28th 2024 | Updated: November 20th 2024
Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems
Published: October 22nd 2024 | Updated: November 20th 2024
Optimizing cGMP Facility Design Space with a Hybrid Approach
Published: October 28th 2024 | Updated: November 20th 2024
Quantifying Chemotherapeutic Cytotoxicity in Glial Cells using AI-Driven Label-Free Cell Analysis
